Treatment options for castrate-resistant prostate cancer

We made it to the end of another series. In our FINAL episode of the prostate cancer series, we turn our attention to metastatic castrate-resistant prostate cancer! We discuss treatment options, the data behind why we do what we do, and more targeted agents.

Content:

- Approach to metastatic castrate-resistant prostate cancer

- Refresher on what it means to be castrate-resistant

- Role of bisphosphate therapy and denosumab

- Treatment options and data surrounding sequencing of agents

- Other options for prostate cancer (radium-223 and lutetium-177-PSMA-617)

- Role of PARP inhibitors in BRCA-mutated disease

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast